Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SI-BONE Inc SIBN

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and... see more

Recent & Breaking News (NDAQ:SIBN)

SI-BONE's iFuse Implant System Surpasses 40,000 Procedures

GlobeNewswire June 27, 2019

SI-BONE Announces the Addition of Mark Foley and Heyward Donigan to the Board of Directors

GlobeNewswire June 17, 2019

SI-BONE to Present at the 2019 JMP Securities Life Sciences Conference

GlobeNewswire June 5, 2019

SI-BONE, Inc. Reports First Quarter 2019 Financial Results

GlobeNewswire May 8, 2019

SI-BONE to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

GlobeNewswire April 29, 2019

SI-BONE To Report First Quarter 2019 Financial Results on May 8, 2019

GlobeNewswire April 24, 2019

SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock(TM) Novel Spinopelvic Fixation Technology

GlobeNewswire April 15, 2019